This provider's $587.9M in total Medicare payments ranks in the 99th percentile of Clinical Laboratory providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $45.83 | $22.22 | 2.06x | $23.61 | $166.0M | 7.5M | 32 |
| 2015 | $60.49 | $21.98 | 2.75x | $38.51 | $156.8M | 7.1M | 36 |
| 2016 | $565.50 | $123.48 | 4.58x | $442.02 | $45.2M | 366.1K | 16 |
| 2017 | $586.54 | $167.41 | 3.50x | $419.13 | $46.8M | 279.7K | 22 |
| 2018 | $358.74 | $160.34 | 2.24x | $198.40 | $43.1M | 268.7K | 20 |
| 2019 | $332.91 | $161.11 | 2.07x | $171.80 | $39.4M | 244.4K | 15 |
| 2020 | $338.76 | $165.55 | 2.05x | $173.21 | $24.5M | 148.0K | 10 |
| 2021 | $332.65 | $163.76 | 2.03x | $168.89 | $24.0M | 146.4K | 9 |
| 2022 | $325.54 | $157.44 | 2.07x | $168.10 | $21.6M | 137.4K | 8 |
| 2023 | $329.44 | $158.46 | 2.08x | $170.98 | $20.4M | 128.9K | 5 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 540.3K | $102.4M | $189.56 | 3.04x |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 281.5K | $67.4M | $239.53 | 2.57x |
| 82542 | Chemical analysis using chromatography technique | 2.2M | $53.3M | $24.04 | 2.89x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 346.9K | $50.8M | $146.38 | 3.03x |
| G6056 | Opiate(s), drug and metabolites, each procedure | 1.1M | $28.3M | $25.92 | 2.95x |
| 83925 | Opiates (drug) measurement | 784.9K | $20.4M | $25.93 | 3.10x |
| 80307 | Testing for presence of drug, by chemistry analyzers | 263.1K | $17.4M | $66.15 | 1.88x |
| 81226 | Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants | 39.2K | $17.3M | $441.49 | 1.48x |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 161.6K | $16.9M | $104.35 | 2.76x |
| 82649 | Dihydromorphinone (drug) level | 334.7K | $11.4M | $34.18 | 1.06x |
| G6046 | Dihydromorphinone | 307.3K | $10.5M | $34.21 | 2.56x |
| 81225 | Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants | 33.1K | $9.4M | $285.19 | 1.41x |
| 82646 | Dihydrocodeinone (drug) measurement | 335.0K | $9.2M | $27.45 | 1.06x |
| G6058 | Drug confirmation, each procedure | 510.1K | $9.0M | $17.63 | 3.62x |
| 82205 | Barbiturates level | 561.8K | $8.6M | $15.24 | 1.06x |
| G6045 | Dihydrocodeinone | 307.2K | $8.4M | $27.48 | 2.56x |
| G6042 | Amphetamine or methamphetamine | 387.7K | $8.0M | $20.68 | 3.13x |
| 80154 | Benzodiazepines level | 324.8K | $8.0M | $24.61 | 2.51x |
| 83840 | Methadone level | 360.0K | $7.8M | $21.72 | 2.50x |
| 80184 | Phenobarbital level | 488.8K | $7.4M | $15.23 | 1.69x |
This provider submits charges 2.57 times higher than what Medicare actually pays.
A markup ratio of 2.57x means for every $100 Medicare pays, this provider initially charges $257. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Genomic Health, Inc. | Redwood City, CA | $887.6M | ✓ Clear |
| Unilab Corporation | West Hills, CA | $868.8M | ⚠️ Flagged |
| Caredx Inc. | Brisbane, CA | $751.0M | ✓ Clear |
| Laboratory Corporation Of America | San Diego, CA | $592.4M | ⚠️ Flagged |
| Guardant Health, Inc. | Redwood City, CA | $498.0M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data